Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1635 1644 1647
This examiner grants 15% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17769322 | Treatment of Airway Conditions by Modulation of MiR200 Family MicroRNAs | Non-Final OA | The Regents of the University of California |
| 17359181 | RNA INTERFERENCE AGENTS FOR GST-PI GENE MODULATION | Final Rejection | Nitto Denko Corporation |
| 18158290 | COMPOSITIONS AND METHODS FOR MODULATING PKK EXPRESSION | Non-Final OA | Ionis Pharmaceuticals, Inc. |
| 17481679 | COMPOSITIONS AND METHODS FOR MODULATING TAU EXPRESSION | Non-Final OA | Ionis Pharmaceuticals, Inc. |
| 17576562 | ENGINEERED ITR SEQUENCES AND METHODS OF USE | Non-Final OA | BIOVERATIV THERAPEUTICS INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy